Paper Details
- Home
- Paper Details
Efficacy of highly active antiretroviral therapy in HIV-1 infected children.
Author: FraaijPieter L A, de GrootRonald, van RossumAnnemarie M C
Original Abstract of the Article :
Although the reduction in HIV-1-related deaths with highly active antiretroviral therapy (HAART) is similar in adults and children, the extent of the changes in two important surrogate markers HIV-1 RNA levels and CD4+ T cell counts, differs widely. In most paediatric studies virological response ra...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s1473-3099(02)00183-4
データ提供:米国国立医学図書館(NLM)
Tackling HIV-1 in Children: Exploring the Efficacy of Highly Active Antiretroviral Therapy (HAART)
This review explores the challenges and triumphs of treating HIV-1 infection in children using highly active antiretroviral therapy (HAART). The researchers, like dedicated healers in a bustling desert marketplace, analyzed data from 23 paediatric clinical studies, seeking to understand the factors that influence the effectiveness of HAART in children. The review highlights the complexities of treating HIV-1 in children, emphasizing the need for personalized approaches that consider individual factors and drug pharmacokinetics.
The Evolving Landscape of HIV-1 Treatment
This review provides a comprehensive overview of the evolving landscape of HIV-1 treatment in children. The findings, like a tapestry woven from diverse threads of research, reveal that while HAART has significantly reduced HIV-1-related deaths in children, the virological response rates are often lower than those observed in adults. The review underscores the need for ongoing research to improve treatment strategies and optimize drug dosages for children.
Navigating the Challenges of HIV-1 Treatment in Children
This review highlights the unique challenges of treating HIV-1 infection in children. The study emphasizes the importance of considering individual factors, such as drug pharmacokinetics and adherence to treatment regimens, when developing treatment strategies. Just as a skilled caravan leader navigates the desert, healthcare providers must work closely with children and their families to ensure optimal treatment outcomes.
Dr.Camel's Conclusion
This review provides a valuable overview of the challenges and triumphs of treating HIV-1 infection in children using highly active antiretroviral therapy (HAART). The findings, like a beacon of hope in the desert of HIV-1 research, highlight the need for personalized approaches that consider the unique characteristics of each child and the evolving nature of the disease. Ongoing research is crucial to improve treatment outcomes and ensure a brighter future for children living with HIV-1.
Date :
- Date Completed 2002-03-26
- Date Revised 2022-03-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.